SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-020526
Filing Date
2024-08-01
Accepted
2024-08-01 17:00:06
Documents
2
Period of Report
2024-07-30

Document Format Files

Seq Description Document Type Size
1 form4-08012024_050801.html 4  
1 form4-08012024_050801.xml 4 4062
2 ex24-08012024_050801.htm EX-24 5921
  Complete submission text file 0001415889-24-020526.txt   11364
Mailing Address 500 PLAZA DRIVE SECAUCUS NJ 07094
Business Address
Rona Jeffrey A (Reporting) CIK: 0001311404 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 241167644

Mailing Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001
Business Address 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)